Tamçelik Nevbahar, Capar Olgu, Atalay Eray
Department of Ophthalmology, Istanbul University Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey.
Department of Ophthalmology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey.
J Curr Glaucoma Pract. 2019 Sep-Dec;13(3):88-93. doi: 10.5005/jp-journals-10078-1263.
To present the results of our case series with a technique we defined as "modified viscotrabeculotomy" which incorporates the benefits of 360° of trabeculotomy and viscodilation and viscodissection of canal of Schlemm using a microcatheter.
This study was designed as a prospective interventional case series and was conducted in Cerrahpasa Medical School Ophthalmology Clinic. Forty-one eyes of 30 patients diagnosed with congenital glaucoma (CG) underwent modified viscotrabeculotomy surgery following initial preoperative examination. The main outcome measure was the surgical success of the procedure, which is determined by an intraocular pressure (IOP) of <18 mm Hg without medication or resurgery; qualified success is defined as an IOP of <18 mm Hg under general anesthesia with an additional need for medications. The differences in IOP measurements were analyzed using paired analysis of variance (ANOVA) with repeated measures.
The mean preoperative IOP of the patients was 32.27 ± 4.89 mm Hg. The IOP values at the 1st, 3rd, 6th postoperative months, and at the last visit were 13.41 ± 2.25 mm Hg, 13.70 ± 1.78 mm Hg, 12.47 ± 1.57 mm Hg, and 12.26 ± 1.81 mm Hg, respectively. The difference between the preoperative IOP values and postoperative IOP values was statistically significant ( < 0.001). The qualified surgical success rate was 94.4% after a mean follow-up of 27.95 ± 8.25 months (range 15-45 months).
Modified viscotrabeculotomy is a safe and effective treatment in the management of CG.
Tamçelik N, Capar O, Atalay E. Modified Viscotrabeculotomy with Microcatheter: Our Technique and Experience in the Surgical management of Glaucoma. J Curr Glaucoma Pract 2019;13(3):88-93.
展示我们采用一种被定义为“改良粘小管切开术”的技术所得到的病例系列结果,该技术融合了360°小梁切开术以及使用微导管对施莱姆管进行粘弹扩张和粘弹分离的优点。
本研究设计为前瞻性干预性病例系列,在切拉帕萨医学院眼科诊所进行。30例诊断为先天性青光眼(CG)的患者的41只眼睛在进行初步术前检查后接受了改良粘小管切开术。主要观察指标是手术成功率,其定义为无需药物治疗或再次手术时眼压(IOP)<18 mmHg;合格成功定义为在全身麻醉下眼压<18 mmHg且额外需要药物治疗。使用重复测量的配对方差分析(ANOVA)分析眼压测量值的差异。
患者术前平均眼压为32.27±4.89 mmHg。术后第1、3、6个月以及最后一次随访时的眼压值分别为13.41±2.25 mmHg、13.70±1.78 mmHg、12.47±1.57 mmHg和12.26±1.81 mmHg。术前眼压值与术后眼压值之间的差异具有统计学意义(<0.001)。平均随访27.95±8.25个月(范围15 - 45个月)后,合格手术成功率为94.4%。
改良粘小管切开术是治疗先天性青光眼的一种安全有效的方法。
Tamçelik N, Capar O, Atalay E. 微导管改良粘小管切开术:我们在青光眼手术治疗中的技术与经验。《当代青光眼实践杂志》2019;13(3):88 - 93。